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considered cryopreserved vein as an alternative conduit, especially
in patients with active cancer?
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Dr E. John Harris, Jr (Stanford, Calif). Dr Quinones, Dr
Katz, members, and guests, I am happy to comment on this
well-presented paper by Dr Dhanisetty and the OHSU group. This
is a retrospective study generated by reviewing a prospective oper-
ative log, with the fem-pop vein harvest CPT code as the inclusion
criteria. As a retrospective review, many details of individual pro-
cedures just are not available, but general demographics are col-
lated and are not particularly enlightening. Cancer patients
undergoing mostly venous interposition grafting during por-
tomesenteric reconstruction following Whipple-type procedures
have a high rate (52%) of postoperative DVT in the harvest leg, but
harvest for arterial reconstruction for infection also led to ipsilateral
DVT, but the true rate remains elusive since prospective duplex
scanning of all harvest limbs is not part of the authors’ protocol,
and occurred in only 60% of the cohort, 28% of whom had a DVT.
Symptomatic legs only were scanned, with 100% of DVT showing
obstruction distal to the harvest, and 31% of these patients also
showing DVT proximal to the harvest. The overall rate of 28% for
symptomatic post harvest limb DVT should command our atten-
tion following femoral vein harvest, especially with PE noted in
3.4% of their patients. Prophylaxis against perioperative DVT
appeared uneven in this mixed population of cancer and noncancer
patients with varying scopes of procedures leading to variable risks
of postoperative bleeding if routine perioperative chemical prophy-
laxis would be employed identically in all patients. Wound compli-
cations occurred in 20% of patients, but most of these resolved with
minimal attention.
My questions are few, but ask in general, what have you
learned from this infrequent, roughly 10 patients per year experi-
ence? Do you perform your harvest before or concomitantly as
multiple teams with the index procedure? Were any vein harvests
performed while the patient was systemically anticoagulated, and if
yes, was their DVT rate lessened? Do you routinely now recom-
mend therapeutic rather than prophylactic heparin or heparinoid
dosing perioperatively in active cancer patients? If not, why not?
Based on the significant incidence of DVT in the harvest leg, do
you now routinely scan all harvest limbs perioperatively? Have youDr Ravi V. Dhanisetty. Thank you, Dr Harris, for your
omments.
Femoral vein is not required for most arterial and venous
econstructions, so the experience at any one center is limited. Our
ohort of 58 cases is comparable to previous series, the largest of
hich was 61 patients. Our study population, however, had a
ignificant number of patients with cancer; different from prior
eries. As a retrospective study, there are a number of limitations in
ur data, but it is clear femoral vein harvest has low short-term
orbidity in patients without cancer. Cancer patients, however,
learly have more trouble with venous thrombosis. Based on our
ata, patients with cancer, particularly pancreatic cancer, undergo-
ng femoral vein harvest would seem to have indications for routine
ostoperative screening for DVT and extended DVT prophylaxis.
Timing of the FVH depended on the index procedure. For
ost arterial reconstructions, the vein was harvested before or
oncomitantly with the procedure. In the setting of cancer, most of
he oncological resection was performed first, followed by vein
arvest and venous reconstruction.
None of the procedures were performed with the patient on
ystemic anticoagulation for the entire procedure. All patients
eceived full-dose heparin prior to the clamp placement and vascu-
ar reconstruction. The heparin was not routinely reversed.
For patients with cancer, we do now routinely scan all harvest
imbs postoperatively but do not believe, given the magnitude of
hese resections, that therapeutic anticoagulation is indicated im-
ediately postoperatively in all patients with cancer that undergo
emoral vein harvest. We do recommend prolonged pharmacologic
rophylaxis with LMWH and believe routine screening in this
opulation is indicated to diagnose DVT.
Most of the patients with cancer and femoral vein harvest in
ur series were undergoing pancreatic resection. There have been
eports of using alternate conduits in close proximity to a pancre-
tic anastomosis, but the possibility or bile or pancreatic leak in
lose proximity to the venous reconstruction leads us to prefer
utogenous conduit for these reconstructions. We have used cry-
vein for venous reconstruction in selected patients with cancer
here the possibility of contamination of the conduit is minimal.
